Osaic Holdings
COGT icon

Osaic Holdings’s Cogent Biosciences COGT Stock Holding History

Osaic Holdings’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Buy
4,130
+2,021
+96% +$70.7K ﹤0.01% 4596
2026
Q1 		$81.2K Sell
2,109
-6,378
-75% -$236K ﹤0.01% 4838
2025
Q4 		$301K Buy
8,487
+4,496
+113% +$126K ﹤0.01% 3808
2025
Q3 		$56.7K Sell
3,991
-559
-12% -$6.62K ﹤0.01% 5226
2025
Q2 		$32.5K Buy
4,550
+1,333
+41% +$7.39K ﹤0.01% 5351
2025
Q1 		$19.3K Buy
3,217
+688
+27% +$5.39K ﹤0.01% 5390
2024
Q4 		$19.7K Buy
2,529
+49
+2% +$488 ﹤0.01% 5353
2024
Q3 		$26.8K Buy
2,480
+694
+39% +$6.76K ﹤0.01% 5183
2024
Q2 		$15.1K Buy
+1,786
New +$13.5K ﹤0.01% 5535
2023
Q4 		– Sell
-17
Closed -$166 – 7330
2023
Q3 		$166 Hold
17
– – ﹤0.01% 7181
2023
Q2 		$201 Buy
17
+9
+113% +$103 ﹤0.01% 7207
2023
Q1 		$86 Buy
+8
New +$102 ﹤0.01% 7343
2020
Q2 		– Sell
-63
Closed – – 6140
2020
Q1 		$0 Buy
+63
New +$175 ﹤0.01% 6077

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Osaic Holdings's COGT Position: Q2 2026 in Review

Osaic Holdings increased its Cogent Biosciences (COGT) stake by 96% in Q2 2026, buying an estimated $70.7K and bringing the position to 4,130 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #4596.

Osaic Holdings first reported a position in COGT in Q1 2020 and has held it in 13 quarters since. The position peaked at $301K in Q4 2025. 323 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Osaic Holdings held 4,130 shares of Cogent Biosciences worth $160K as of Q2 2026.
  • Osaic Holdings bought 2,021 Cogent Biosciences shares in Q2 2026, an estimated $70.7K.
  • Cogent Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4596 holding.
  • Osaic Holdings first reported a position in Cogent Biosciences in Q1 2020 and has held it in 13 quarters since.
  • Osaic Holdings's Cogent Biosciences position peaked at $301K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.